CGEM Cullinan Therapeutics, Inc.

NEUTRAL Impact: 3/10 Institutional Cluster
Horizon weeks Processed 2d 3h ago
Institutional cluster: 3 buyers, 2 sellers (mixed)

Executive Summary

Three institutional investors (Morgan Stanley, Invesco, RenTech) added to their CGEM positions in Q3 2025, while two (Fidelity, UBS) trimmed. The net buying of $1.3M is modest relative to the $741M market cap, and the cluster is dominated by passive/quant funds, limiting the signal's conviction. The historical calibration suggests high-impact scores in this segment have negative expected alpha, reinforcing a cautious read.

Key Financial Metrics

Direction
mixed
Buy Value
$6.1M
Sell Value
$2.3M
Net Flow
$1.3M

Institutional Positions

Net institutional flow: $1.3M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Morgan Stanley ADD +65.3% $2.4M $550.0K
Invesco ADD +69% $607.0K $151.0K
RenTech ADD +58.3% $3.1M $620.0K

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
Fidelity TRIM -74.6% $29.0K -$23.0K
UBS TRIM -39.6% $2.3M -$1.2M

Actionable Insight

The cluster is too small and passive-dominated to drive a directional trade. Monitor for a higher-conviction catalyst (e.g., pipeline data, partnership) before acting. The 95% analyst bullish consensus is already priced in.

Key Facts

  • 3 buyers added $1.3M in net new holdings; 2 sellers reduced by $1.25M
  • Largest buyer: RenTech added $620K (+58.3% shares), now holds $3.1M
  • Largest seller: UBS trimmed $1.2M (-39.6% shares), now holds $1.1M
  • All participants are passive/quant funds — no activist or high-conviction active managers
  • 13F data is as of 2025-09-30; positions may have been unwound since

Financial Impact

Net institutional buying of ~$1.3M against a $741M market cap (~0.2% of float)

institutional ownershipfloat

Risk Factors

  • 13F data is 45+ days stale; positions may have reversed
  • No active manager participation reduces signal reliability
  • Historical calibration shows negative expected alpha for high-impact scores in this segment

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
95% bullish (19 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CGEM-2025-Q3
10 reports for CGEM
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+5▲ +9.49%May 18, 2026
Filters
Rows
Reports for CGEM — sortable, filterable
Type Now
Jun 11, 2026
2d ago
Institutional Cluster
NEUTRAL ★ 3/10
$12.04 awaiting T+5awaiting T+5
Jun 10, 2026
3d ago
Press Release
NEUTRAL ★ 4/10
$13.20 awaiting T+5awaiting T+5
Jun 8, 2026
5d ago
8-K
BULLISH ★ 6/10
$13.51 awaiting T+5awaiting T+5
May 19, 2026
25d ago
Press Release
BULLISH ★ 5/10
$14.18 $15.52▲ +9.49%▲ +7.19%
May 18, 2026
25d ago
8-K
BULLISH ★ 5/10
$14.18 $15.52▲ +9.49%▲ +7.19%
May 18, 2026
25d ago
Press Release
NEUTRAL ★ 5/10
$14.18 $15.52▲ +9.49%▲ +7.19%
Mar 10, 2026
13w ago
Press Release
NEUTRAL ★ 5/10
$14.91 $13.44▼ −9.86%▼ −8.95%
Feb 24, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$14.27 $15.73▼ −10.23%▼ −11.26%
Feb 24, 2026
15w ago
Insider Cluster
BEARISH ★ 6/10
$14.27 $15.73▼ −10.23%▼ −11.26%
Feb 24, 2026
15w ago
Insider Cluster
BEARISH ★ 6/10
$14.27 $15.73▼ −10.23%▼ −11.26%
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (45h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access